The Brexit transition period ended on 31 December 2020 and there is finally a deal between the United Kingdom and the European Union. However, many relevant practical questions for businesses remain open and still need to be resolved especially in the Pharma & Life Sciences sector.Continue reading Webinar – After the Brexit deal: what you need to know and do next – 18 January, 9am
Dear pharma & life sciences colleagues
Brexit is coming closer every day with many aspects still unclear which makes it hard for you to prepare for it.
We’re excited to take a closer look at the current status quo and the impact of Brexit on indirect taxes, movement of goods and trade for Pharma, Life Sciences and MedTech Companies.Continue reading The impact of Brexit on Pharma, Life Science and MedTech companies – A PwC Pharma & Life Sciences Webinar
The year 2020 has seen a lot of development in the way we do business such as new regulations and smarter solutions to solve old and new challenges. PwC has identified the following hot topics for Pharma & Life Sciences which need our special attention:Continue reading PwC’s Pharma & Life Sciences Hot Topics 2020